中国实用外科杂志

• 指南(共识)解读 • 上一篇    下一篇

NCCN《软组织肉瘤临床实践指南(2016年第2版)》胃肠间质瘤部分更新介绍与解读

汪    明,曹    晖   

  1. 上海交通大学医学院附属仁济医院胃肠外科,上海200127
  • 出版日期:2016-09-01 发布日期:2016-08-24

  • Online:2016-09-01 Published:2016-08-24

摘要:

胃肠间质瘤(gastrointestinal stromal tumor,GIST)的诊断和治疗已日趋标准化和规范化。近10余年来,随着分子水平发病机制的揭示和小分子酪氨酸激酶受体抑制剂的成功应用,GIST已经成为精准医疗时代最经典的实体肿瘤靶向治疗成功范例之一。2016年2月,美国国立综合癌症网络(NCCN)发布了最新版的《软组织肉瘤临床实践指南(2016年第2版)》,与既往版本相比,新版指南中GIST部分内容突出了野生型GIST规范化诊断与治疗,并在<2 cm的胃极小GIST的随访策略及GIST的恶性潜能评估等方面做出了部分调整。

关键词: 胃肠间质瘤, 美国国立综合癌症网络

Abstract:

Updates and interpretations of the NCCN Clinical Practice Guidelines (2016 second version) on gastrointestinal stromal tumor        WANG Ming, CAO Hui. Department of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China
Corresponding author: CAO Hui, E-mail: caohuishcn@hotmail.com
Abstract    The diagnosis and treatment of gastrointestinal stromal tumor (GIST) is getting more and more standardized. In the last decade, due to the revelation of the molecular mechanism of its tumorigenesis, as well as the effectiveness of tyrosine kinase inhibitors, GIST has become well known as one of the most classical model of target therapy on solid tumor in the precision medicine era. The National Comprehensive Cancer Network (NCCN) issued the latest version of clinical practice guideline on GIST in Feb. 2016. The updated guideline emphasized the importance of the management of wild-type GIST, also updated the surveillance strategy of very small gastric GIST (<2cm), and the predictor of GIST biological behavior. This paper provides interpretations of these updates, aiming to improve the clinical practice of GIST.

Key words: gastrointestinal stromal tumor, National Comprehensive Cancer Network